REVIEW: γ‐Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State

Aims: Drugs currently used for the treatment of Alzheimer's disease (AD) partially stabilize patients’ symptoms without modifying disease progression. Brain accumulation of oligomeric species of β‐amyloid (Aβ) peptides, the principal components of senile plaques, is believed to play a crucial r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:CNS Neurosci Ther
Egile Nagusiak: Panza, Francesco, Frisardi, Vincenza, Imbimbo, Bruno P., Capurso, Cristiano, Logroscino, Giancarlo, Sancarlo, Daniele, Seripa, Davide, Vendemiale, Gianluigi, Pilotto, Alberto, Solfrizzi, Vincenzo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Publishing Ltd 2010
Gaiak:
Alzheimer's Disease
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493789/
https://ncbi.nlm.nih.gov/pubmed/20560993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2010.00164.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak